Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Since Trump has Big Pharma’s back, we can surely expect he’ll push their wishlist — yet another reason governments have to reject his attempts to strong-arm them. Meanwhile, a similar move is afoot in ...

Drug patents are relatively short-lived, so big pharma companies must constantly launch new products to overcome inevitable losses to generic competition. If drugmakers find it extra challenging ...

In a press release announced Monday, the company’s CEO Nathan Schultz explained that he believes “macroeconomic trends will continue to put pressure on our company and business trends will ...

The UK big pharma company will pay $1.2bn upfront for Boston’s subsidiary BP Asset IX, which will give the company access to efimosfermin. GSK has also agreed to pay additional milestone payments ...

very big announcement to make — like as big as it gets,” Trump said last week. He came into his first term accusing pharmaceutical companies of “getting away with murder” and complaining ...

During today's morning press conference at the White House, Donald Trump accuses countries in the European Union (EU) for price gouging and profiteering off big pharmaceutical companies.

Grocery retail chain Aldi has purchased a small handful of Big Lots locations less than a year after Big Lots filed for Chapter 11 bankruptcy and announced plans to close hundreds of stores.

“In a room with the big leaguers of the FDA, I asked them what made them decide that GLP-1s were not on the (drug shortage) list? And they said, ‘well, the pharmaceutical companies are telling us that ...